Summary
In this report we have tried to determine whether or not catecholamines are involved in the progressive muscular dystrophy. Catecholamines and their metabolites were studied in urines of children with Duchenne disease or other forms of myopathy (limb-girdle and facio-scapulo humeral myopathies). Catecholamine deaminated metabolites were normal in either form of myopathy; in contrast, Duchenne patients, contrarily to other children, eliminated excessive amounts of most amines (catecholamines and methoxylated amines) in relation to age and degree of disease evolution.
Our results indicate that catecholamines are not the primary factors involved in the pathogenesis of Duchenne myopathy, but are rather secondary to some disease effects. It is suggested that the high excretion of catecholamines and their methoxylated amine metabolites observed in severely affected Duchenne boys might be related to thermoregulatory processes or/and to alterations in some enzymatic systems.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ashmore, C. R., Doerr, L., Somes, R. G., jr. Microcirculation: loss of an enzyme in chickens with hereditary muscular dystrophy. Science160, 319–320 (1968).
Axelrod, J. Enzymic oxidation of epinephrine to adrenochrome by the salivary gland. Biochim. Biophys. Acta85, 247–254 (1964).
Bacq, Z. M. The metabolism of adrenaline. Pharmacol. Rev.1, 1–26 (1949).
Brown, H. D., Chattpadhyay, S. K., Patel, Al. Erythrocyte abnormality in human myopathy. Science157, 1577–1578 (1967).
Burcb, G. E., Sun, S. C., Colcolough, H. L. Acute myocardial lesions following experimentally induced intracranial hemorrhage in mice. Arch. Pathol.84, 517–521 (1969).
Cazzato, G. Considerations about a possible role played by connective tissue proliferation and vascular disturbances in the pathogenesis of progressive muscular dystrophy. European Neurology1, 158–179 (1968).
Claustre, B.: Étude systématique des variations du métabolisme des catécholamines en fonction de la nature de l'apport alimentaire chez l'Homme. Thèse 3ème Cycle, Lyon, 1976.
Coërs, C., Telerman-Toppet, N. Morphological changes of motor units in Duchenne's muscular dystrophy. Arch. Neurol.34, 396–402 (1977).
Costa, E., Sandier, M. Monoamine oxidases-new vistas. New York: Raven Press. 1972.
Cottet-Emard, J. M., Peyrin, L. An improved fluorimetric method for assay of DOPA in urine and tissues and its use for determination of urinary DOPA, at endogenous level in different species. J. of Neural Transmission41, 145–173 (1977).
Dalmaz, Y., Peyrin, L. Specific ion exchange chromatography and fluorimetric assay for urinary 3-0 methyldopamine. J. of Chromatography116, 379–394 (1976).
Dalmaz, Y., Peyrin, L. Rapid procedure for Chromatographie isolation of DOPA, DOPAC, epinephrine, norepinephrine and dopamine from a single urinary sample at endogenous levels. J. of Chromatography145, 11–27 (1978).
Demos, J. Un nouveau problème posé par la myopathie humaine: les troubles des temps de circulation et leur liaison avec l'activité enzymatique sérique. Bull, et Mém. Soc. Med. Hôp. Paris16 et17, 636–646 (1961).
Demos, J. Présence d'une aminodiphénoloxydase dans les plaquettes sanguines humaines. Existence d'un variant de cette enzyme chez les malades atteints de myopathie (forme de Duchenne de Boulogne). C.R. Acad. Sci. (Paris)267, 677–680 (1968).
Demos, J.: Théorie microcirculatoire de la myopathie. Actual. Path. Neuromusculaire, 297–309 (1971).
Demos, J. Platelet diphenoloxydase in progressive muscular dystrophy. Clin. Genetics4, 79–90 (1973).
Demos, J., Berthelon, M. Enzymologie et myopathie. Arch. fr. Pediat.29, 793–799 (1972).
Engel, W. K. Nouvelle hypothèse sur la pathogénie de la dystrophie musculaire pseudohypertrophique de Duchenne. Revue Neurologique124, 291–298 (1971).
Engel, W. K., Derrer, E. C. Drugs blocking the muscle damaging effects of 5-HT and noradrenaline in aorta ligatured rats. Nature254, 151–152 (1975).
Fischer, P., Lecomte, J. Métabolisme de l'adrénochrome, de ses produits de réduction et du trihydroxy-N-methylindol chez le Lapin, le Chat et le Chien. Bull. Soc. Chim. Biol.33, 569–600 (1951).
Goodall, Mc C., Alton, H. Urinary excretion of adrenaline metabolites in man during intervals of 2 minutes, 5 minutes and 10 minutes after intravenous injection of adrenaline. Biochem. Pharmacol.14, 1595 to 1604 (1965).
Gordon, P. Aberration of catecholamine metabolism in muscular dystrophy. Fed. Proceed.21, 345 (1962).
Gordon, P., Dowben, R. M. Catecholamine distribution in mice afflicted with muscular dystrophy. Am. J. Physiol.210, 728–732 (1966).
Hathaway, P. W., Engel, W. K., Zellweger, H. Experimental myopathy after microarterial embolization. Arch. Neurol.22, 365–378 (1970).
Hegedus, Z. L., Altschule, M. D. Studies on rheomelanins in human blood plasma from catecholamines, from L-DOPA and from some of their derivatives. Arch. int. Physiol. Bioch.78, 443–459 (1970).
Hendley, E. D. The mechanism of extraneuronal transport of catecholamines in the central nervous system in the mechanism of neuronal and extra-neuronal transport of catecholamines (Paton, D. M., ed.). New York: Raven Press. 1976.
Hermann, H., Mornex, R.: Les Phéochromocytomes. Ed. Gauthier-Villars. 1964.
Herschberg, A. G., Coirault, R., Giboudeau, J. La myopathie de Duchenne (dystrophie musculaire progressive) et glandes endocrines. La Clinique60, 181–196 (1965).
Heymsfield, S. B., McNisb, T., Perkins, J. V., Feiner, J. M. Sequence of cardiac changes in Duchenne muscular dystrophy. Am. Heart J.95, 283–293 (1978).
Himms-Hagen, J. Effects of catecholamines on metabolism. In: Catecholamines (Blaschko, H., Murscboll, E., eds.), pp. 363–462. New York: Springer. 1972.
Iversen, L. L. Catecholamines uptake processes. Brit. Med. Bull.29, 130 to 135 (1973).
Iyer, S. L., Hoenig, P. A., Sherblom, A. P., Howland, J. L. Membrane function affected by genetic muscular dystrophy. Biochem. Med.18, 384–391 (1977).
Jucbtnes, J.: Étude du mécanisme d'excrétion urinaire des catécholamines (adrénaline et noradrénaline) chez le Mammifère. Thesis, University of Liège, 1977.
Kabara, J. J., Rlggin, R. M., Kissinger, P. T. Abnormal levels of urinary catecholamines in dystrophie mice and hamsters. Proceed. Soc. Exp. Biol. Med.151, 168–172 (1976).
Kakulas, B. A.: Aetiological mechanisms in progressive muscular dystrophy. Acta Path. Muscul. II. Journées int. de Marseille1970, 35–40.
Kar, N. C., Pearson, C. M. Monoamine oxydase activity in normal and dystrophie human muscle. Clinica Chimica Acta50, 431–433 (1974).
Koch, E. The in vivo detection of some oxidation products of adrenalin and noradrenalin (coming from adrenochrome and noradrenochrome) by fluorimetric spectrophotometric and paper Chromatographie analysis. Int. J. Neuropsychiatry2, 227–233 (1966).
Kopin, I. J. Metabolic degradation of catecholamines. The relative importance of different pathways under physiological conditions and after administration of drugs. In: Catecholamines (Blaschko, H., Muscholl, E., eds.), pp. 270–282. New York: Springer. 1972.
Labrosse, E. H., Mann, J. D., Kety, S. S. The physiological and psychological effects of intravenously administred epinephrine and its metabolism in normal and schizophrenic men. J. Psychiatrical Res.1, 68–75 (1961).
Leskova, N. N., Smirnov, V. F., Sitnikov, V. F., Sychev, V. K. Study of the muscular blood flow with133Xe in progressing muscular dystrophy. Met. Radiol. (Mosk.)22, 34–38 (1977).
Maas, J. W. The effects of psychopharmacological agents on central nervous system amine metabolism in man. Ann. Rev. Pharmacol. Toxicol.17, 411–424 (1977).
Maas, J. W., Landis, D. H. The metabolism of circulating norepinephrine by human subjects. J. Pharmacol. exp. Therap.177, 600–611 (1971).
McComas, A. J. Neural hypothesis of muscular dystrophy is flourishing. Nature251, 569–570 (1974).
McComas, A. J., Sica, R. E. P., Campbell, M. J. “Sick” motoneurones: a unifying concept of muscle disease. Lancet1, 321–325 (1971).
Mawatari, S., Shonberg, M., Olarte, M. Biochemical abnormalities of erythrocyte membranes in Duchenne dystrophy. Arch. Neurol.33, 489 to 493 (1976).
Mawatari, S., Takagi, A., Rowland, L. P. Adenycyclase in normal and pathological human muscle. Arch. Neurol.30, 96–102 (1974).
Meek, J. L., Neff, N. H. Acidic and neutral metabolites of norepinephrine: their metabolism and transport from brain. J. of Pharmacol. and Exp. Ther.181, 457–470 (1972).
Mendell, J. R., Engel, W. K., Derrer, E. C. Duchenne muscular dystrophy: functional ischemia reproduces its characteristic lesions. Science172, 1143–1145 (1971).
Mendell, J. R., Murphy, D. L., Engel, W. K., Chase, T. N., Gordon, E. Catecholamines and indoleamines in patients with Duchenne muscular dystrophy. Arch. Neurol.27, 518–520 (1972).
Murphy, D. L., Mendell, J. R., Engel, W. K. Serotonin and platelet function in Duchenne muscular dystrophy. Arch. Neurol.28, 239–241 (1973).
Paget, M., Gontier, M., Liefooghe, J. Recherches sur le dosage de la créatinine urinaire. Ann. Biol. Clin.13, 535–553 (1955).
Parker, J. M., Mendell, J. R. Proximal myopathy induced by 5-HT imipramine stimulate Duchenne dystrophy. Nature247, 103–104 (1974).
Patten, B. M., Katharine, L. O., Engel, W. K. Serotonin-induced muscle weakness. Arch. Neurol.31, 347–349 (1974).
Pearson, T. W. (Na+K+)ATPase of Duchenne muscular dystrophy erythrocyte ghosts. Life Sciences22, 127–132 (1978).
Peyrin, L. Dosage de la métadrénaline et de la normétadrénaline urinaires. Rev. fr. Et. Clin. Biol.13, 88–92 (1968).
Peyrin, L., Dalmaz, Y. La sécrétion et l'inactivation périphériques des catécholamines. J. Physiol. (Paris)70, 353–433 (1975).
Peyrin, L., Cottet-Emard, J. M. Automated specific fluorimetric methods for epinephrine and norepinephrine assay in a single biological extract. Analyt. Biochem.56, 515–531 (1973).
Peyrin, L., Cottet-Emard, J. M., Claustre, B. Studies on urinary DOPAC in man by means of a sensitive automated procedure. Biochem. Med.19, 318–343 (1978).
Robert, J. M., Guibaud, P.: La dystrophie musculaire progressive infantile. Ed. SIMEP, 1966.
Rowland, L. P. Pathogenesis of muscular dystrophies. Arch. Neurol.33, 315–321 (1976).
Sha'Afi, R. I., Rodan, S. B., Hintz, R. L., Fernandez, S. M., Rodan, G. A. Abnormalities in membrane microviscosity and ion transport in genetic muscular dystrophy. Nature254, 525–526 (1975).
Souweine, G., Bernard, J. C., Lasne, Y., Lachanat, J. The sodium pump of erythrocytes from patients with Duchenne muscular dystrophy: effect of ouabain on the active sodium flux and on (Na+K+)ATPase. J. Neurol.217, 287–294 (1978).
Spector, R., Lorenzo, A. V. The effect of salicylate and probenecid on the cerebropinal fluid transport of penicillin, aminosalycilic acid and iodide. J. of Pharmacol. and exp. Ther.188, 55–65 (1974).
Stern, P., Hukovic, S., Misirlija, A. Über die Ausscheidung des Adrenalin und Noradrenalin by Dystrophia musculorum progressiva. Arch. exp. Path, und Pharmak.228, 209–211 (1956).
Tuil, D., Berthelon, M., Demos, J. Distribution des diphenoloxydases (DP ox) dans divers tissus de diverses espèces animales. Clin. Chim. Acta61, 219–227 (1975).
Werning, C., Siegenthaler, W. Diagnostik des Phäochromozytoms. Deutsche Med. Wschr.3, 121–124 (1971).
Wright, T. L., Oison, W. H. Abnormal intrafibrillar monoamine accumulation in Duchenne muscular dystrophy. Neurology22, 424 (1972).
Yu, M. K., Wright, T. L., Dettbarn, W. D., Olson, W. H. Pargyline induced myopathy with histochemical characteristics of Duchenne dystrophy. Neurology24, 237–244 (1974).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dalmaz, Y., Peyrin, L., Mamelle, J.C. et al. The pattern of urinary catecholamines and their metabolites in Duchenne myopathy, in relation to disease evolution. J. Neural Transmission 46, 17–34 (1979). https://doi.org/10.1007/BF01243426
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01243426